SLPI Antikörper (Middle Region)

Produktnummer ABIN318889

Produktdetails anti-SLPI Antikörper

Target: SLPI (Secretory Leukocyte Peptidase Inhibitor (SLPI))

Bindungsspezifität: Middle Region

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SLPI Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Aufreinigung: Purified

Immunogen: A 17 amino acid peptide located near the centre of human SLPI.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Western Blot: 1.0 - 2.0g/mL, detects a band of approximately 14 kDa in Daudi cell lysates.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1.0 mg/mL

Buffer: Phosphate buffered saline containing 0.02 % Sodium Azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Details zu SLPI

Target: SLPI (Secretory Leukocyte Peptidase Inhibitor (SLPI))

Andere Bezeichnung: Antileukoproteinase (ALP) (SLPI Produkte)

Synonyme: ALK1 antikoerper, ALP antikoerper, BLPI antikoerper, HUSI antikoerper, HUSI-I antikoerper, MPI antikoerper, WAP4 antikoerper, WFDC4 antikoerper, MATN4 antikoerper, SLPI antikoerper, ckpi antikoerper, secretory leukocyte peptidase inhibitor antikoerper, antileukoproteinase antikoerper, SLPI antikoerper, Slpi antikoerper, LOC102174044 antikoerper

Hintergrund: SLPI is a 14kD non-glycosylated protein produced by secretory cells in the respiratory, genital and lacrimal glands, and by macrophages, B-cells and neutrophils. The functions of SLPI are diverse. The SLPI protein inhibits protease activity at sites of inflammation, protecting tissues against protease mediated damage and it possesses anti-microbial/anti-viral activity. In addition, SLPI has been reported to exhibit anti-inflammatory properties, regulating lipopolysaccharide induced activation of NF-kappa beta in peripheral blood monocytes.Synonyms: BLPI, HUSI-1, Mucus proteinase inhibitor, Protease inhibitor WAP4, SLPI, Secretory leukocyte protease inhibitor, Seminal proteinase inhibitor, WAP four-disulfide core domain protein 4, WAP4, WFDC4

Gen-ID: 9606

UniProt: P03973